Tenet Healthcare Reports Strong Q3 2026 Results with Significant EPS Growth and Raised EBITDA Guidance
Tenet Healthcare (THC) reported robust third-quarter 2026 financial results, characterized by a 79.5% year-over-year increase in adjusted diluted earnings per share to $6.64. Net operating revenues rose 6.5% to $5.631 billion, driven largely by strong performance in ambulatory care and high-acuity services. The company also raised its full-year 2026 adjusted EBITDA outlook to a range of $5.05 billion to $5.20 billion. While the hospital segment saw growth in admissions, the company faced headwinds from an 18% decline in exchange admissions and revenues, which impacted the overall payer mix. To strengthen its balance sheet, Tenet completed a multiyear debt refinancing initiative, issuing $2 billion in senior unsecured notes to retire upcoming maturities. The company continues to prioritize shareholder returns, having repurchased approximately 8 million shares year-to-date.
Topics: Adjusted Diluted EPS EBITDA Free Cash Flow Hospital Admissions Net Operating Revenues Share Repurchases